Stress- (and diet-) related regulation of hepatic nuclear receptors and its relevance for ABC-transporter functions

Drug Metabolism Reviews

Volumn 36, Issue 2, 2004, Pages 391-406

  Stienstra, Rinke ^a   Lichtenauer Kaligis, Elgin ^a   Müller, Michael ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

ABC transporter; Hepatic; Nuclear receptors; PPAR

Indexed keywords

ABC TRANSPORTER; ACUTE PHASE PROTEIN; CELL NUCLEUS RECEPTOR; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; ROSIGLITAZONE; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

BILE FLOW; CONFERENCE PAPER; DIET; DIETARY INTAKE; DOWN REGULATION; ENZYME SUBSTRATE; FATTY ACID METABOLISM; FUNCTIONAL ASSESSMENT; HOMEOSTASIS; HUMAN; IMMUNOMODULATION; INFLAMMATION; LIVER FUNCTION; LIVER METABOLISM; PROTEIN FUNCTION; STRESS;

ACUTE-PHASE REACTION; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; DIET; HEPATITIS; HUMANS; LIVER; LIVER CIRRHOSIS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; STRESS;

EID: 3042606885     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-120037573     Document Type: Conference Paper

References (63)

1. Angulo, P. (2002). Nonalcoholic fatty liver disease. N. Engl. J. Med. 346(16):1221-1231.
2. Beigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., Feingold, K. R. (2000). The acute phase response is associated with retinoid X receptor repression in rodent liver. Biol. Chem. 275(21):16390-16399.
3. Beigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., Feingold, K. R. (2002). Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem. Biophys. Res. Commun. 293(1):145-149.
4. Blanquart, C., Barbier, O., Fruchart, J. C., Staels, B., Glineur, C. (2003). Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J. Steroid Biochem. Mol. Biol. 85(2-5):267-273.
5. Boelsterli, U. A., Bedouchac, M. (2002). Toxicological consequences of altered peroxisome proliferator-activated receptor (PPARγ) expression in the liver: insights from models of obesity and type 2 diabetes. Biochem. Pharmacol. 63:1-10.
6. Cabrero, A., Laguna, J. C., Vazquez, M. (2002). Peroxisome proliferator-activated receptors and the control of inflammation. Curr. Drug Targets Inflamm. Allergy 1(3):243-248.
7. Castrillo, A., Joseph, S. B., Vaidya, S. A., Haberland, M., Fogelman, A. M., Cheng, G., Tontonoz, P. (2003). Crosstalk between LXR and toll-like receptor signalling mediates bacterial and viral antagonism of cholesterol metabolism. Mol. Cell 12(4):805-816.
8. Cesari, M., Penninx, B. W., Newman, A. B., Kritchevsky, S. B., Nicklas, B. J., Sutton-Tyrrell, K., Rubin, S. M., Ding, J., Simonsick, E. M., Harris, T. B., Pahor, M. (2003). Inflammatory markers and onset of cardiovascular events: results from the health ABC study. Circulation 108(19):2317-2322.
9. Chou, C. J., Haluzik, M., Gregory, C., Dietz, K. R., Vinson, C., Gavrilova, O., Reitman, M. L. (2002). WY14, 643, A peroxisome proliferator-activated receptor alpha (PPARalpha) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice. J. Biol. Chem. 277(27):24484-24489.
10. Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J. C., Tedgui, A., Haegeman, G., Staels, B. (1999). Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J. Biol. Chem. 274(45):32048-32054.
11. Delerive, P., De Bosscher, K., Vanden Berghe, W., Fruchart, J. C., Haegeman, G., Staels, B. (2002). DNA binding-independent induction of IkappaBalpha gene transcription by PPARalpha. Mol. Endocrinol. 16(5):1029-1039.
12. Desreumaux, P., Dubuquoy, L., Nutten, S. (2001). Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer: a basis for new therapeutic strategies. Exp. Med. 193:827-838.
13. Desvergne, B., Wahli, W. (1999). Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20(5):649-688.
14. Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., Wahli, W. (1996). The PPARα-leukotriene B4 pathway to inflammation control. Nature 384(6604):39-43.
15. Dubuquoy, L., Dharancy, S., Nutten, S., Pettersson, S., Auwerx, J., Desreumaux, P. (2002). Role of peroxisome proliferator-activated receptor and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 360(9343): 1410-1418.
16. Galli, A., Crabb, D. W., Ceni, E., Salzano, R., Mello, T., Svegliati-Baroni, G., Ridolfi, F., Trozzi, L., Surrenti, C., Casini, A. (2002). Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 122(7):1924-1940.
17. Gelman, L., Fruchart, J. C., Auwerx, J. (1999). An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer. Cell. Mol. Life Sci. 55(6-7):932-943.
18. Gervois, P., Vu-Dac, N., Kleemann, R., Kockx, M., Dubois, G., Laine, B., Kosykh, V., Fruchart, J. C., Kooistra, T., Staels, B. (2001). Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta. J. Biol. Chem. 276(36):33471-33477.
19. Ghosh, S., May, M. J., Kopp, E. B. (1998). NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
20. Handschin, C., Meyer, U. A. (2003). Induction of drug metabolism: the role of nuclear receptors. Pharmacol. Rev. 55(4):649-673.
21. Hellemans, K., Michalik, L., Dittie, A., Knorr, A., Rombouts, K., De Jong, J., Heirman, C., Quartier, E., Schuit, F., Wahli, W., Geerts, A. (2003). Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells. Gastroenterology 124(1):184-201.
22. Heyninck, K., Wullaert, A., Beyaert, R. (2003). Nuclear factor-kappa B plays a central role in tumour necrosis factor-mediated liver disease. Biochem. Pharmacol. 66(8):1409-1415.
23. Hoekstra, M., Kruijt, J. K., Van Eck, M., Van Berkel, T. J. (2003). Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells. J. Biol. Chem. 278(28):25448-25453.
24. Ip, E., Farrell, G. C., Robertson, G., Hall, P., Kirsch, R., Leclercq, I. (2003). Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 38:123-132.
25. Juge-Aubry, C. E., Hammar, E., Siegrist-Kaiser, C., Pemin, A., Takeshita, A., Chin, W. W., Burger, A. G., Meier, C. A. (1999). Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent transactivating domain. J. Biol. Chem. 274(15):10505-10510.
26. Karpen, S. J. (2002). Nuclear receptor regulation of hepatic function. J. Hepatol. 36(6):832-850.
27. Kersten, S. (2002). Peroxisome proliferator activated receptors and obesity. Eur. J. Pharmacol. 440:223-234.
28. Kersten, S., Seydoux, J., Peters, J. M., Gonzalez, F. J., Desvergne, B., Wahli, W. (1999). Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J. Clin. Invest. 103(11):1489-1498.
29. Khovidhunkit, W., Moser, A. H., Shigenaga, J. K., Grunfeld, C., Feingold, K. R. (2003). Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: Differential role of LXR. J. Lipid Res. 44:1728-1736.
30. Kim, M. S., Shigenaga, J., Moser, A., Feingold, K., Grunfeld, C. (2003). Repression of farnesoid X receptor during the acute phase response. J. Biol. Chem. 278(11):8988-8995.
31. Kleemann, R., Gervois, P. P., Verschuren, L., Staels, B., Princen, H. M., Kooistra, T. (2003). Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NF kB-C/EBP-complex formation. Blood 101(2):545-551.
32. Kok, T., Bloks, V. W., Wolters, H., Havinga, R., Jansen, P. L. M., Staels, B., Kuipers, F. (2003). Peroxisome proliferator-activated receptor a (PPARα)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice. Biochem. J. 369:539-547.
33. Kon, K., Ikejima, K., Hirose, M., Yoshikawa, M., Enomoto, N., Kitamura, T., Takei, Y., Sato, N. (2002). Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride. Biochem. Biophys. Res. Commun. 291(1):55-61.
34. Laffitte, B. A., Joseph, S. B., Walczak, R., Pei, L., Wilpitz, D. C., Collins, J. L., Tontonoz, P. (2001). Autoregulation of the human liver X receptor α promoter. Mol. Cell. Biol. 21(22):7558-7568.
35. Lee, C. H., Olson, P., Evans, R. M. (2003). Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144(6):2201-2207.
36. Li, Q., Verma, I. M. (2002). NF-kappaB regulation in the immune system. Nat. Rev., Immunol. 2(10):725-734.
37. Madej, A., Okopien, B., Kowalski, J., Zielinski, M., Wysocki, J., Szygula, B. (1998). Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia Hb. Int. J. Clin. Pharmacol. Ther. 36:345-349.
38. Mandard, S., Müller, M., Kersten, S. (2004). Peroxisome proliferator-activated receptor alpha target genes. Cell. Mol. Life Sci. 61(4):393-416.
39. Marcellin, P., Asselah, T., Boyer, N. (2002). Fibrosis and disease progression in hepatitis C. Hepatology 36(5 Suppl. 1):s47-s57.
40. Marchesini, G., Forlani, G. (2002). NASH and the metabolic syndrome. Hepatology 35(2):497-499.
41. Mohan, R., Heyman, R. A. (2003). Orphan nuclear receptor modulators. Curr. Top. Med. Chem. 3(14):1637-1647.
42. Moshage, H. (1997). Cytokines and the hepatic acute phase response. J. Pathol. 181:257-266.
43. Müller, M., Kersten, S. (2003). Nutrigenomics: goals and strategies. Nat. Rev., Genet. 4:315-322.
44. Neuschwander-Tetri, B. A., Brunt, E. M., Wehmeier, K. R., Oliver, D., Bacon, B. R. (2003). Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone. Hepatology 38:1008-1017.
45. Nuclear Receptors Committee. (1999). A unified nomenclature system for the nuclear receptor subfamily. Cell 97(2):161-163.
46. Okaya, T., Lentsch, A. B. (2004). Peroxisome proliferator-activated receptor-alpha regulates post-ischemic liver injury. Am. J. Physiol. Gasterointest. Liver Physiol. 286(4):G606-G612.
47. Pineda Torra, I., Jamshidi, Y., Flavell, D. M., Fruchart, J. C., Staels, B. (2002). Characterization of the human PPARα promoter: identification of a functional nuclear receptor response element. Mol. Endocrinol. 16(5):1013-1028.
48. Pineda Torra, I., Claudel, T., Duval, C., Kosykh, V., Fruchart, J. C., Staels, B. (2003). Bile acids induce the expression of the human peroxisome proliferator-activated receptor α gene via activation of the farnesoid X receptor. Mol. Endocrinol. 17(2):259-272.
49. Roberts, R. A., Chevalier, S., Hasmall, S. C., James, N. H., Cosulich, S. C., Macdonald, N. (2002). PPAR alpha and the regulation of cell division and apoptosis. Toxicology 181-182:167-170.
50. Saxena, R., Zucker, S. D., Crawford, J. M. (2003). Anatomy and physiology of the liver. In: Zakim, D., Boyer, T. D., Saunders, eds. Hepatology, A Textbook of Liver Disease. Vol. 1. 4th ed. Saunders, Elsevier Science, pp. 3-30.
51. Schoonjans, K., Staels, B., Auwerx, J. (1996). Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37:907-925.
52. Scotto, K. W. (2003). Transcriptional regulation of ABC drug transporters. Oncogene 22(47):7496-7511.
53. Sekiya, M., Yahagi, N., Matsuzaka, T., Najima, Y., Nakakuki, M., Nagai, R., Ishibashi, S., Osuga, J., Yamada, N., Shimano, H. (2003). Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 38(6):1529-1539.
54. Shalev, A., Siegrist-Kaiser, C. A., Yen, P. M., Wahli, W., Burger, A. G., Chin, W. W., Meier, C. A. (1996). The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulin. Endocrinology 137(10):4499-4502.
55. Stravitz, R. T., Sanyal, A. J. (2003). Drug-induced steatohepatitis. Clin. Liver Dis. 7(2):435-451.
56. Tanaka, T., Itoh, H., Doi, K., Fukunaga, Y., Hosoda, K., Shintani, M. (1999). Down regulation of peroxisome proliferator-activated receptor g expression by inflammatory cytokines and its reversal by thiazolidinediones. Diabetologia 42(6):702-710.
57. Tugwood, J. D., Aldridge, T. C., Lambe, K. G., Macdonald, N., Woodyatt, N. J. (1996). Peroxisome proliferator-activated receptors: structures and function. Ann. N.Y. Acad. Sci. 804:252-265.
58. Uchimura, K., Nakamuta, M., Enjoji, M., Irie, T., Sugimoto, R., Muta, T., Iwamoto, H., Nawata, H. (2001). Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells. Hepatology 33(1):91-99.
59. Viollet, B., Kahn, A., Raymondjean, M. (1997). Protein kinase A-dependent phosphorylation modulates DNA-binding activity of hepatocyte nuclear factor 4. Mol. Cell. Biol. 17(8):4208-4219.
60. Wang, Y. X., Lee, C. H., Tiep, S., Yu, R. T., Ham, J., Kang, H., Evans, R. M. (2003). Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113:159-170.
61. Watt, A. J., Garrison, W. D., Duncan, S. A. (2003). HNF4: a central regulator of hepatocyte differentiation and function. Hepatology 37(6):1249-1253.
62. Xu, J., Fu, Y., Chen, A. (2003). Activation of peroxisome proliferator-activated receptor-γ contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am. J. Physiol. Gasterointest. Liver Physiol. 285:G20-G30.
63. Yu, S., Matsusue, K., Kashireddy, P., Cao, W. Q., Yeldandi, V., Yeldandi, A. J., Rao, M., Gonzalez, F. J., Reddy, J. K. (2003). Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor γ1 (PPARγ 1) overexpression. J. Biol. Chem. 278(1):498-505.